Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death

Neurochemistry International

Volumn 88, Issue , 2015, Pages 110-123

  Domin, Helena ^a   Jantas, Danuta ^a   ͆miałowska, Maria ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Calpains; Caspase 3; Ischemia; mGluR7; MMPIP; Neuroprotection

Indexed keywords

CALPAIN; CASPASE 3; GLUCOSE; KAINIC ACID; LACTATE DEHYDROGENASE; METABOTROPIC RECEPTOR 7; N,N' DIBENZHYDRYLETHYLENEDIAMINE; NEUROPROTECTIVE AGENT; OXYGEN; BENZHYDRYL DERIVATIVE; METABOTROPIC RECEPTOR; N,N'-DIBENZHYDRYLETHANE-1,2-DIAMINE DIHYDROCHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL CULTURE; BRAIN CORTEX; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MOUSE; MTT ASSAY; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; AGONISTS; ALLOSTERISM; ANIMAL; CELL CULTURE; CELL HYPOXIA; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ALLOSTERIC REGULATION; ANIMALS; BENZHYDRYL COMPOUNDS; CELL DEATH; CELL HYPOXIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; KAINIC ACID; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84928795485     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.12.010     Document Type: Article

References (108)

1. R.T. Bartus, K.L. Baker, A.D. Heiser, S.D. Sawyer, R.L. Dean, P.J. Elliott, and et al. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage J. Cereb. Blood Flow Metab 14 1994 537 544
2. L. Belayev, R. Busto, Zhao W., and M.D. Ginsberg HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat Stroke 26 1995 2313 2320
3. S.R. Bradley, A.I. Levey, S.M. Hersch, and P.J. Conn Immunocytochemical localization of group III metabotropic glutamate receptors in the hippocampus with subtype-specific antibodies J. Neurosci 16 1996 2044 2056
4. S.R. Bradley, H.D. Rees, Yi H., A.I. Levey, and P.J. Conn Distribution and developmental regulation of metabotropic glutamate receptor 7a in rat brain J. Neurochem 71 1998 636 645
5. J.H. Brandstätter, P. Koulen, R. Kuhn, H. van der Putten, and H. Wässle Compartmental localization of a metabotropic glutamate receptor (mGluR7): two different active sites at a retinal synapse J. Neurosci 16 1996 4749 4756
6. G.J. Brewer Serum-free B27/neurobasal medium supports differentiated growth of neurones from the striatum, substantia nigra, septum, cerebral cortex, cerebellum and dentate gyrus J. Neurosci. Res 42 1995 674 683
7. V. Bruno, G. Battaglia, A. Copani, R.G. Giffard, G. Raciti, R. Raffaele, and et al. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration Eur. J. Neurosci 7 1995 1906 1913
8. V. Bruno, A. Copani, L. Bonanno, T. Knoepfel, R. Kuhn, P.J. Roberts, and et al. Activation of group III metabotropic glutamate receptors is neuroprotective in cortical cultures Eur. J. Pharmacol 310 1996 61 66
9. V. Bruno, G. Battaglia, I. Ksiazek, H. van der Putten, M.V. Catania, R. Giuffrida, and et al. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death J. Neurosci 20 2000 6413 6420
10. V. Bruno, G. Battaglia, A. Copani, M. D'Onofrio, P. Di Iorio, A. De Blasi, and et al. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs J. Cereb. Blood Flow Metab 21 2001 1013 1033
11. K.R. Byrnes, D.J. Loane, and A.I. Faden Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders Neurother 6 2009 94 107
12. P.T. Canas, L.J. Velly, C.N. Labrande, B.A. Guillet, V. Sautou-Miranda, F.M. Masmejean, and et al. Sevoflurane protects rat mixed cerebrocortical neuronal-glial cell cultures against transient oxygen-glucose deprivation: involvement of glutamate uptake and reactive oxygen species Anesthesiology 105 2006 990 998
13. Cao G., Xing J., Xiao X., A.K. Liou, Gao Y., Yin X.M., and et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury J. Neurosci 27 2007 9278 9293
14. F. Caraci, G. Battaglia, M.A. Sortino, S. Spampinato, G. Molinaro, A. Copani, and et al. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic? Neurochem. Int 61 2012 559 565
15. J. Cartmell, and D.D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem 75 2000 889 907
16. G.V. Chaitanya, and P.P. Babu Activation of calpain, cathepsin-b and caspase-3 during transient focal cerebral ischemia in rat model Neurochem. Res 33 2008 2178 2186
17. D.W. Choi Glutamate receptors and the induction of excitotoxic neuronal death Prog. Brain Res 100 1994 47 51
18. H. Chung, S. Seo, M. Moon, and S. Park Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells J. Endocrinol 198 2008 511 521
19. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Annu. Rev. Pharmacol. Toxicol 37 1997 205 237
20. J.T. Coyle Neurotoxic action of kainic acid J. Neurochem 41 1983 1 11
21. W. Danysz, and C.G. Parsons Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications Pharmacol. Rev 50 1998 597 664
22. H. Domin, M. Kajta, and M. Smiałowska Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures Pharmacol. Rep 58 2006 846 858
23. H. Domin, K. Gołembiowska, D. Jantas, K. Kamińska, B. Zięba, and M. Smiałowska Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo Neurotox. Res 26 2014 99 113
24. A. Durukan, and T. Tatlisumak Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia Pharmacol. Biochem. Behav 87 2007 179 197
25. A.I. Faden, S.A. Ivanova, A.G. Yakovlev, and A.G. Mukhin Neuroprotective effects of group III mGluR in traumatic neuronal injury J. Neurotrauma 14 1997 885 895
26. J.W. Ferkany, and J.T. Coyle Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids J. Pharmacol. Exp. Ther 225 1983 399 406
27. J.W. Ferkany, R. Zaczek, and J.T. Coyle Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors Nature 298 1982 757 759
28. F. Ferraguti, and R. Shigemoto Metabotropic glutamate receptors Cell Tissue Res 326 2006 483 504
29. F. Ferraguti, B. Baldani-Guerra, M. Corsi, S. Nakanishi, and C. Corti Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors Eur. J. Neurosci 11 1999 2073 2082
30. J. Folbergrová, R. Druga, R. Haugvicová, P. Mares, and J. Otáhal Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid Neuropharmacology 54 2008 665 675
31. S. Fujimoto, H. Katsuki, T. Kume, S. Kaneko, and A. Akaike Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures Neurosci. Res 50 2004 179 187
32. T. Gáspár, B. Kis, J.A. Snipes, G. Lenzsér, K. Mayanagi, F. Bari, and et al. Transient glucose and amino acid deprivation induces delayed preconditioning in cultured rat cortical neurons J. Neurochem 98 2006 555 565
33. F. Gasparini, V. Bruno, G. Battaglia, S. Lukic, T. Leonhardt, W. Inderbitzin, and et al. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo J. Pharmacol. Exp. Ther 289 1999 1678 1687
34. Ge Q.F., Hu X., Ma Z.Q., Liu J.R., Zhang W.P., Chen Z., and et al. Baicalin attenuates oxygen-glucose deprivation-induced injury via inhibiting NMDA receptor-mediated 5-lipoxygenase activation in rat cortical neurons Pharmacol. Res 55 2007 148 157
35. M.P. Goldberg, and D.W. Choi Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury J. Neurosci 13 1993 3510 3524
36. C. Goudet, E. Chapuy, A. Alloui, F. Acher, J.P. Pin, and A. Eschalier Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain Pain 137 2008 112 124
37. S.H. Graham, and Chen J. Programmed cell death in cerebral ischemia J. Cereb. Blood Flow Metab 21 2001 99 109
38. M. Grammer, Li D., N. Arunthavasothy, and J. Lipski Contribution of calpain activation to early stages of hippocampal damage during oxygen-glucose deprivation Brain Res 1196 2008 121 130
39. Gu Z., Liu W., Wei J., and Yan Z. Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7 J. Biol. Chem 287 2012 10265 10275
40. Gu Z., Cheng J., Zhong P., Qin L., Liu W., and Yan Z. Aβ selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease J. Neurosci 34 2014 13614 13628
41. C. Harms, M. Lautenschlager, A. Bergk, J. Katchanov, D. Freyer, K. Kapinya, and et al. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration J. Neurosci 21 2001 2600 2609
42. P.M. Headley, and S. Grillner Excitatory amino acids and synaptic transmission: the evidence for a physiological function Trends Pharmacol. Sci 11 1990 205 211
43. Huang L., Li Q., Li H., He Z., Cheng Z., Chen J., and et al. Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons Eur. J. Pharmacol 602 2009 238 244
44. L. Iacovelli, V. Bruno, L. Salvatore, D. Melchiorri, R. Gradini, A. Caricasole, and et al. Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways J. Neurochem 82 2002 216 223
45. C. Ikonomidou, and L. Turski Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1 2002 383 386
46. D. Jantas, E. Lorenc-Koci, M. Kubera, and W. Lason Neuroprotective effects of MAPK/ERK1/2 and calpain inhibitors on lactacystin-induced cell damage in primary cortical neurons Neurotoxicology 32 2011 845 856
47. D. Jantas, A. Greda, S. Golda, M. Korostynski, B. Grygier, A. Roman, and et al. Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: the impact of cell differentiation state Neuropharmacology 83 2014 36 53
48. S. Kawasaki-Yatsugi, S. Yatsugi, K. Koshiya, and M. Shimizu-Sasamata Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats Jpn. J. Pharmacol 74 1997 253 260
49. J.M. Kinzie, M.M. Shinohara, A.N. van den Pol, G.L. Westbrook, and T.P. Segerson Immunolocalization of metabotropic glutamate receptor 7 in the rat olfactory bulb J. Comp. Neurol 385 1997 372 384
50. A. Kochhar, J.A. Zivin, and V. Mazzarella Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia J. Neurotrauma 8 1991 175 186
51. K. Koga, Y. Iwahori, S. Ozaki, and H. Ohta Regulation of spontaneous Ca(2+) spikes by metabotropic glutamate receptors in primary cultures of rat cortical neurons J. Neurosci. Res 88 2010 2252 2262
52. C.M. Kosinski, S. Risso Bradley, P.J. Conn, A.I. Levey, G.B. Landwehrmeyer, J.B. Penney Jr., and et al. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia J. Comp. Neurol 415 1999 266 284
53. M. Kovalska, L. Kovalska, M. Pavlikova, M. Janickova, K. Mikuskova, M. Adamkov, and et al. Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury Neurochem. Res 37 2012 1568 1577
54. M. Lafon-Cazal, L. Fagni, M.J. Guiraud, S. Mary, M. Lerner-Natoli, J.P. Pin, and et al. mGluR7-like metabotropic glutamate receptors inhibit NMDA-mediated excitotoxicity in cultured mouse cerebellar granule neurons Eur. J. Neurosci 11 1999 663 672
55. Lai T.W., Zhang S., and Wang Y.T. Excitotoxicity and stroke: identifying novel targets for neuroprotection Prog. Neurobiol 2014 115 2014 157 188
56. H. Lavreysen, and F.M. Dautzenberg Therapeutic potential of group III metabotropic glutamate receptors Curr. Med. Chem 15 2008 671 684
57. P.M. Lea 4th., and A.I. Faden Modulation of metabotropic glutamate receptors as potential treatment for acute and chronic neurodegenerative disorders Drug News Perspect 16 2003 513 522
58. K.S. Lee, S. Frank, P. Vanderklish, A. Arai, and G. Lynch Inhibition of proteolysis protects hippocampal neurons from ischemia Proc. Natl. Acad. Sci. U.S.A. 88 1991 7233 7237
59. P. Lipton Ischemic cell death in brain neurons Physiol. Rev 79 1999 1431 1568
60. Liu R., Yuan H., Yuan F., and Yang S.H. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke Neurol. Res 34 2012 331 337
61. Liu W., Liu R., J.T. Chun, Bi R., W. Hoe, S.S. Schreiber, and et al. Kainate excitotoxicity in organotypic hippocampal slice cultures: evidence for multiple apoptotic pathways Brain Res 916 2001 239 248
62. K. Maiese, A. Vincent, Lin S.H., and T. Shaw Group I and group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection J. Neurosci. Res 62 2000 257 272
63. K. Maiese, Chong Z.Z., and Li F. Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors Curr. Neurovasc. Res 2 2005 425 446
64. C. Malagelada, X. Xifró, A. Miñano, J. Sabriá, and J. Rodríguez-Alvarez Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures Neurobiol. Dis 20 2005 27 37
65. I. Marabese, F. Rossi, E. Palazzo, V. de Novellis, K. Starowicz, L. Cristino, and et al. Periaqueductal gray metabotropic glutamate receptor subtype 7 and 8 mediate opposite effects on amino acid release, rostral ventromedial medulla cell activities, and thermal nociception J. Neurophysiol 98 2007 43 53
66. R. Martín, M. Torres, and J. Sánchez-Prieto mGluR7 inhibits glutamate release through a PKC-independent decrease in the activity of P/Q-type Ca2+ channels and by diminishing cAMP in hippocampal nerve terminals Eur. J. Neurosci 26 2007 312 322
67. G.L. Mazzone, and A. Nistri Delayed neuroprotection by riluzole against excitotoxic damage evoked by kainate on rat organotypic spinal cord cultures Neuroscience 190 2011 318 327
68. G.L. Mazzone, G. Margaryan, A. Kuzhandaivel, S.E. Nasrabady, M. Mladinic, and A. Nistri Kainate-induced delayed onset of excitotoxicity with functional loss unrelated to the extent of neuronal damage in the in vitro spinal cord Neuroscience 168 2010 451 462
69. C. Millán, R. Luján, R. Shigemoto, and J. Sánchez-Prieto The inhibition of glutamate release by metabotropic glutamate receptor 7 affects both [Ca2+]c and cAMP: evidence for a strong reduction of Ca2+ entry in single nerve terminals J. Biol. Chem 277 2002 14092 14101
70. J. Minnerup, B.A. Sutherland, A.M. Buchan, and C. Kleinschnitz Neuroprotection for stroke: current status and future perspectives Int. J. Mol. Sci 13 2012 11753 11772
71. K. Mitsukawa, R. Yamamoto, S. Ofner, J. Nozulak, O. Pescott, S. Lukic, and et al. A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo Proc. Natl. Acad. Sci. U.S.A. 102 2005 18712 18717
72. S.G. Moyanova, F. Mastroiacovo, L.V. Kortenska, R.G. Mitreva, E. Fardone, I. Santolini, and et al. Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage J. Cereb. Blood Flow Metab 31 2011 1107 1118
73. K.W. Muir, and K.R. Lees Clinical experience with excitatory amino acid antagonist drugs Stroke 26 1995 503 513
74. Y. Nakajima, H. Iwakabe, C. Akazawa, H. Nawa, R. Shigemoto, N. Mizuno, and et al. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate J. Biol. Chem 268 1993 11868 11873
75. R.W. Neumar, Meng F.H., A.M. Mills, Xu Y.A., Zhang C., F.A. Welsh, and et al. Calpain activity in the rat brain after transient forebrain ischemia Exp. Neurol 170 2001 27 35
76. D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, Ding C.K., M. Gallant, and et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 376 1995 37 43
77. F. Nicoletti, V. Bruno, A. Copani, G. Casabona, and T. Knöpfel Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19 1996 267 271
78. K. Nozaki, M. Nishimura, and N. Hashimoto Mitogen-activated protein kinases and cerebral ischemia Mol. Neurobiol 23 2001 1 19
79. Y. Nuñez-Figueredo, J. Ramírez-Sánchez, R. Delgado-Hernández, M. Porto-Verdecia, E. Ochoa-Rodríguez, Y. Verdecia-Reyes, and et al. JM-20, a novel benzodiazepine-dihydropyridine hybrid molecule, protects mitochondria and prevents ischemic insult-mediated neural cell death in vitro Eur. J. Pharmacol 726 2014 57 65
80. H. Ohishi, C. Akazawa, R. Shigemoto, S. Nakanishi, and N. Mizuno Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain J. Comp. Neurol 360 1995 555 570
81. J.W. Olney Neurotoxicity of excitatory amino acids E.G. McGeer, J.W. Olney, P.L. McGeer, Kainic Acid as a Tool in Neurobiology 1978 Raven Press New York 95 112
82. J.W. Olney, and M.J. Ishimaru Excitotoxic cell death V.E. Koliatsos, R.R. Ratan, Cell Seath and Diseases in the Nervous System 1999 Humana Press Totowa, NJ 197 220
83. M.J. O'Neill, A. Bond, P.L. Ornstein, M.A. Ward, C.A. Hicks, K. Hoo, and et al. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia Neuropharmacology 37 1998 1211 1222
84. M.J. O'Neill, L. Bogaert, C.A. Hicks, A. Bond, M.A. Ward, G. Ebinger, and et al. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia Neuropharmacology 39 2000 1575 1588
85. A. Pałucha, K. Klak, P. Branski, H. van der Putten, P.J. Flor, and A. Pilc Activation of the mGlu7 receptor elicits antidepressant-like effects in mice Psychopharmacology (Berl) 194 2007 555 562
86. A. Pałucha-Poniewiera, and A. Pilc A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats Behav. Brain Res 238 2013 109 112
87. A. Pałucha-Poniewiera, P. Brański, T. Lenda, and A. Pilc The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent J. Pharmacol. Exp. Ther 334 2010 1066 1074
88. A. Panatier, D.A. Poulain, and S.H. Oliet Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus Neuropharmacology 47 2004 333 341
89. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
90. K. Prass, and U. Dirnagl Glutamate antagonists in therapy of stroke. Glutamate antagonists in therapy of stroke Restor. Neurol. Neurosci 13 1998 3 10
91. W. Pulsinelli Pathophysiology of acute ischaemic stroke Lancet 339 1992 533 536
92. J. Puyal, V. Ginet, and P.G. Clarke Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection Prog. Neurobiol 105 2013 24 48
93. K.E. Saatman, H. Murai, R.T. Bartus, D.H. Smith, N.J. Hayward, B.R. Perri, and et al. Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat Proc. Natl. Acad. Sci. U.S.A. 93 1996 3428 3433
94. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther 299 2001 12 20
95. R. Shigemoto, A. Kulik, J.D. Roberts, H. Ohishi, Z. Nusser, T. Kaneko, and et al. Target-cell-specific concentration of a metabotropic glutamate receptor in the presynaptic active zone Nature 381 1996 523 525
96. R. Shigemoto, A. Kinoshita, E. Wada, S. Nomura, H. Ohishi, M. Takada, and et al. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus J. Neurosci 17 1997 7503 7522
97. R. Siman, and J.C. Noszek Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo Neuron 1 1988 279 287
98. R. Siman, J.C. Noszek, and C. Kegerise Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage J. Neurosci 9 1989 1579 1590
99. W. Spooren, T. Ballard, F. Gasparini, M. Amalric, V. Mutel, and R. Schreiber Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders Behav. Pharmacol 14 2003 257 277
100. G. Suzuki, N. Tsukamoto, H. Fushiki, A. Kawagishi, M. Nakamura, H. Kurihara, and et al. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists J. Pharmacol. Exp. Ther 323 2007 147 156
101. P. Syntichaki, and N. Tavernarakis The biochemistry of neuronal necrosis: rogue biology? Nat. Rev. Neurosci 4 2003 672 684
102. Tian Y., Liu Y., Chen X., Kang Q., Zhang J., Shi Q., and et al. AMN082 promotes the proliferation and differentiation of neural progenitor cells with influence on phosphorylation of MAPK signaling pathways Neurochem. Int 57 2010 8 15
103. A. Ugolini, C.H. Large, and M. Corsi AMN082, an allosteric mGluR7 agonist that inhibits afferent glutamatergic transmission in rat basolateral amygdala Neuropharmacology 55 2008 532 536
104. L.J. Velly, B.A. Guillet, F.M. Masmejean, A.L. Nieoullon, N.J. Bruder, F.M. Gouin, and et al. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters Anesthesiology 99 2003 368 375
105. Wang Q., Yu S., A. Simonyi, Sun G.Y., and Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration Mol. Neurobiol 31 2005 3 16
106. Wang W.Y., Wang H., Luo Y., Jia L.J., Zhao J.N., Zhang H.H., and et al. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway Neuroscience 205 2012 167 177
107. Xu S.Y., and Pan S.Y. The failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy Med. Sci. Monit. Basic Res 19 2013 37 45
108. Zhao L., Qian Z.M., Zhang C., H.Y. Wing, Du F., and K. Ya Amyloid beta-peptide 31-35-induced neuronal apoptosis is mediated by caspase-dependent pathways via cAMP-dependent protein kinase A activation Aging Cell 7 2008 47 57